State workers’ access to weight loss drugs has put House Speaker Tim Moore at odds with State Treasurer Dale Folwell, who ran ...

The most common symptom was stomach problems but some also experienced blurred vision, depression and dizziness. Four deaths ...

U.S. representative from Austin asks Health and Human Services secretary to push for generic licensing of semaglutide ...

Some people have turned to compound pharmacies to replace drugs in short supply, but medical professionals warn of a new ...

D’où le développement d’un médicament de la même famille, mais cette fois contre l’obésité : le Wegovy (semaglutide dosé à 2,4 mg). Par voie injectable, une fois par semaine ...

Novo shares fell as much as 4.6% to a seven-month low on Friday after a JPMorgan Chase & Co. analyst said the Danish firm’s ...

U.S. telehealth company Hims & Hers Health on Wednesday said it will sell compounded versions of Novo Nordisk's popular ...

On Tuesday, congressional leaders spent two hours taking to task Novo Nordisk Chief Executive Officer Lars Fruergaard ...

That same report found that the obesity fighting drug Wegovy goes for $1,349 in the U.S. compared to $140 in Germany. Norvo ...

Wegovy is a once-weekly injection approved by the U.S. Food and Drug Administration (FDA) to treat obesity in people 12 and ...

Novo Nordisk's weight loss drug Wegovy could face Medicare price negotiations next. Meanwhile, Particle Health files an ...

Ozempic was approved in the US in late 2017 for diabetes, but its powerful effect on weight loss led to significant off-label use. Wegovy, the same medicine in a slightly higher dose, was approved in ...